Autoantibody profiling to predict response to the anti-PD-1 therapy, pembrolizumab, in rare tumors
2025 · ESMO Open · 1 citations
https://doi.org/10.1016/j.esmoop.2025.105518
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
132
Papers
3.8K
Citations
38
h-index
72
i10-index
Matthias Bräutigam is an academic researcher from University of Cologne. The author has contributed to research in topics: Dermatology and Skin Diseases & Allergic Rhinitis and Sensitization & Contact Dermatitis and Allergies. The author has an h-index of 38, co-authored 113 publications.
Click to start Chat